René Bruno
Impact in
- Oncology top 1%
- Cancer Treatment and Pharmacology
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
- Modeling and Simulation top 1%
Papers in
- Oncology 57
- Cancer Treatment and Pharmacology 22
- Cancer Immunotherapy and Biomarkers 21
- Colorectal Cancer Treatments and Studies 20
-
- Statistical Methods in Clinical Trials 21
- Co-authors
- Laurent Claret (32 shared papers)Jianfeng Lü (7 shared papers)Guy Montay (12 shared papers)Nicole Vivier (9 shared papers)Steve Eppler (3 shared papers)J. Vergniol (4 shared papers)Lewis B. Sheiner (2 shared papers)François Mercier (17 shared papers)
- Journals
- Journal of Clinical Oncology (17 papers)Clinical Pharmacology & Therapeutics (16 papers)Cancer Chemotherapy and Pharmacology (14 papers)CPT Pharmacometrics & Systems Pharmacology (10 papers)The Journal of Clinical Pharmacology (8 papers)
- Partner nations
- FranceUnited StatesSwitzerland
In The Last Decade
René Bruno
127 papers receiving 4.6k citations
Peers
Comparison fields: 5 of 125
- Oncology 2.1k
- Modeling and Simulation 279
- Statistics and Probability 464
- Pharmacology 357
- Cancer Research 523
Countries citing papers authored by René Bruno
This map shows the geographic impact of René Bruno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by René Bruno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites René Bruno more than expected).
Fields of papers citing papers by René Bruno
This network shows the impact of papers produced by René Bruno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by René Bruno. The network helps show where René Bruno may publish in the future.
Co-authors
The 25 scholars most cited alongside René Bruno, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 128 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 349 | |
| 2 | 2008 | 280 | |
| 3 | Phase I and pharmacokinetic study of Taxotere (RP 56976; NSC 628503) given as a short intravenous infusion. | 1993 | 227 |
| 4 | 1996 | 224 | |
| 5 | 2009 | 204 | |
| 6 | 2005 | 202 | |
| 7 | 2006 | 191 | |
| 8 | 2005 | 174 | |
| 9 | The effect of an individual's cytochrome CYP3A4 activity on docetaxel clearance. | 2000 | 157 |
| 10 | 1996 | 127 | |
| 11 | 2016 | 117 | |
| 12 | 2013 | 104 | |
| 13 | 1992 | 98 | |
| 14 | 2001 | 88 | |
| 15 | 2014 | 80 | |
| 16 | 1989 | 71 | |
| 17 | 1997 | 69 | |
| 18 | Alpha-1-acid glycoprotein as an independent predictor for treatment effects and a prognostic factor of survival in patients with non-small cell lung cancer treated with docetaxel. | 2003 | 68 |
| 19 | Pharmacokinetics and metabolism of Taxotere (docetaxel). | 1993 | 68 |
| 20 | 2019 | 63 |
About René Bruno
René Bruno is a scholar working on Oncology, Statistics and Probability, Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology, having authored 128 papers that have together received 4.8k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (22 papers), Cancer Immunotherapy and Biomarkers (21 papers), Statistical Methods in Clinical Trials (21 papers), Colorectal Cancer Treatments and Studies (20 papers), Lung Cancer Treatments and Mutations (17 papers), Cancer Genomics and Diagnostics (16 papers), Mathematical Biology Tumor Growth (11 papers) and Antibiotics Pharmacokinetics and Efficacy (7 papers). The work is most often cited by research in Oncology (2.1k citations), Modeling and Simulation (279 citations), Statistics and Probability (464 citations), Pharmacology (357 citations) and Cancer Research (523 citations). René Bruno has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include Laurent Claret, Jianfeng Lü, Guy Montay, Nicole Vivier, Steve Eppler, J. Vergniol, Lewis B. Sheiner, François Mercier, Bert L. Lum and Athanassios Iliadis. Their work appears in journals such as Journal of Clinical Oncology, Clinical Pharmacology & Therapeutics, Cancer Chemotherapy and Pharmacology, CPT Pharmacometrics & Systems Pharmacology and The Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.